Recherche
-
Recent Advances in Clinical Trials in Multiple System Atrophy
(Current Neurology and Neuroscience Reports, 2024-02-28)Article de revue -
An Item Response Theory analysis of the Unified Multiple System Atrophy Rating Scale
(Parkinsonism and Related Disorders. vol. 94, pp. 40-44, 2021-11-30)Article de revue -
A French cohort for assessing COVID-19 vaccine responses in specific populations
(Nature Medicine. vol. 27, pp. 1319-1321, 2021-07-12)Article de revue -
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial
(Movement Disorders, 2021-04-01)Article de revue -
Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants
(HIV Medicine, 2021-07-01)Article de revue -
Establishment of a French surveillance system of Clostridiodes difficile infection: Comparison of patient's characteristics with other national and European data
(Anaerobe. vol. 69, pp. 102329, 2021-02)Article de revue -
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease
(JAMA neurology, 2022-05-31)Article de revue -
Information during the "Levothyrox (R) crisis" in France in 2017. A study of patients' experiences
(Exercer. n° 167, pp. 395-400, 2020-11)Article de revue -
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort
(Nature Medicine. vol. 28, n° 6, pp. 1199-1206, 2022-06)Article de revue -
Association between COVID-19 infection and work exposure assessed by the Mat-O-Covid job exposure matrix in the CONSTANCES cohort
(Occupational and Environmental Medicine, 2022-09-20)Article de revueLibre accès